Zika: Does Latin American crisis echo ebola outbreak?

1 February 2016
zika-big-1

The dust has yet to settle on a report warning that the international community is ill-prepared to face another infectious disease outbreak and suddenly we are staring down the barrel of a Zika pandemic.

The World Health Organization (WHO) said it is “deeply concerned” by the situation in Latin America, which director-general Dr Margaret Chan described as “explosive.”

Latest figures estimate that as many as four million people could be affected by the mosquito-borne virus which has been linked to thousands of birth defects and cases of Guillain-Barré syndrome, a poorly understood condition in which the immune system attacks the nervous system, sometimes resulting in paralysis.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical